Phase I / IIa

From first-in-human to proof-of-concept, Eurotrials offers solutions for your early phase or phase I studies. With specific partnerships and close relationships with local sites, we deliver the strong support you need at the start of your journey.

The strategy chosen form the beginning is very important and will influence all the project deadlines, budget and ultimate success. This is why early phases/phase I should be well strategized and managed. Our multi-disciplinary teams of regulatory strategists, project managers, market access specialists, and biostatisticians, among others, have experience in completing projects on time, on budget and with the compliance expected from a partner of excellence.

Eurotrials partners with Kymos CRO to provide a single offer to the biopharmaceutical industry, from the preclinical stage to the marketed products. The combined geo-footprint of this partnership opens both companies to new global opportunities. This complementarity allows a better service offer to all biopharmaceutical industry in the development of clinical research projects.